AGPU on Nasdaq

Axe Compute Inc.

Price unavailable

Last updated Oct 16, 2026.

Overview

Compare with Metavesco, Inc., Vemanti Group, Inc. or MGT CAPITAL INVESTMENTS, INC., or pick any stock.

  • TickerAGPU on Nasdaq
  • IndustryFinance Services
  • HeadquartersDE
  • Incorporated inDE2
  • Business address91 43Rd Street, Suite 110, Pittsburgh, Pa 152012
  • Filer categoryNon-accelerated filer, Smaller reporting company2

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

-144404.5%Operating margin3
-186053.4%Net margin3
47.7%Revenue growth, 20253
-488.5%Return on equity3

Where the money goes

Where each dollar of revenue went, fiscal 2025

  • Cost of revenue3¢$72.6K
  • Research and development97¢$2.1M

Out of $125.3K in revenue.3 The company lost money this year.

Financial statements

Revenue456783$125.3K in 2025−91% since 2019
0$500.0K$1.0M$1.5M$2.0M2019: $1.4M$1.4M20192020: $1.3M$1.3M2020−11%2021: $1.4M$1.4M2021+13%2022: $1.5M$1.5M2022+6%2023: $1.6M$1.6M2023+8%2024: $84.8K$84.8K2024−95%2025: $125.3K$125.3K2025+48%
Gross profit45678$797.7K in 2024−9% since 2019
0$500.0K$1.0M$1.5M2019: $879.8K$879.8K20192020: $805.1K$805.1K2020−8%2021: $933.7K$933.7K2021+16%2022: $1.0M$1.0M2022+7%2023: $1.0M$1.0M2023+2%2024: $797.7K$797.7K2024−22%
Operating income456783-$180.9M in 2025+699% since 2019
-$200.0M-$150.0M-$100.0M-$50.0M02019: -$22.6M-$22.6M20192020: -$25.4M-$25.4M2020+12%2021: -$20.4M-$20.4M2021−19%2022: -$26.0M-$26.0M2022+27%2023: -$12.1M-$12.1M2023−53%2024: -$10.3M-$10.3M2024−15%2025: -$180.9M-$180.9M2025+1656%
Net income456783-$233.1M in 2025+1102% since 2019
-$300.0M-$200.0M-$100.0M02019: -$19.4M-$19.4M20192020: -$25.9M-$25.9M2020+33%2021: -$19.7M-$19.7M2021−24%2022: -$25.7M-$25.7M2022+31%2023: -$14.0M-$14.0M2023−46%2024: -$12.7M-$12.7M2024−9%2025: -$233.1M-$233.1M2025+1741%

Every line of the income statement in the latest annual report, as filed.3

Period ending2025-12-312024-12-31
Revenue$125.3K$84.8K
Gains (losses) on digital assets-$152.5M$0
Cost of revenues$72.6K$78.3K
General and administrative$25.9M$7.2M
Operations, research and development$2.1M$2.2M
Sales and marketing$406.2K$833.2K
Total operating expenses$28.6M$10.4M
Total operating (loss)-$180.9M-$10.3M
Other income$806.0K$89.4K
Other expense-$9.0K-$11.5K
Gain (loss) on derivative instruments-$52.7M$1.4K
Loss from continuing operations-$232.9M-$10.2M
Loss from discontinued operations-$241.6K-$2.4M
Net loss-$233.1M-$12.7M
Loss from continuing operations (in dollars per share)-$13-$28
Loss from discontinued operations (in dollars per share)-$0-$7
Net loss per common share, basic and diluted (in dollars per share)-$13.37-$34.83
Weighted average shares used in computation basic and diluted (in shares)17.4M shares363.6K shares

Compare Axe Compute Inc. with another company

Former names

  • Predictive Oncology Inc.Jun 13, 2019 to Dec 11, 20252
  • Precision Therapeutics Inc.Apr 2, 2018 to Jun 4, 20192
  • Skyline Medical Inc.Aug 8, 2013 to Feb 6, 20182
  • BioDrain Medical, Inc.Nov 12, 2008 to Aug 7, 20132

Recent filings

  1. Oct 5, 20268-K
  2. Oct 5, 20263
  3. Oct 5, 20264
  4. Oct 5, 20264
  5. Oct 5, 20264
  6. Oct 5, 20264
  7. Oct 5, 20264
  8. Oct 5, 20264
  9. Sep 17, 20268-K
  10. Sep 9, 20264
  11. Sep 9, 20264
  12. Sep 9, 20264
  13. Sep 9, 20264
  14. Sep 9, 20264
  15. Sep 9, 20264

Every filing from the last three years, summarized. The full record is on SEC EDGAR.1